Vaxart (VXRT)
0.32
0.00 (0.00%)
Upcoming Events
Latest Headlines
Vaxart receives European patent for oral norovirus vaccine technology
August 26, 2026 4:08 PM - StreetInsider
Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology
August 26, 2026 4:07 PM - Globe NewsWire
Form 8-K Vaxart, Inc. For: Aug 21
August 25, 2026 4:13 PM - SEC Filing
Vaxart (VXRT) Misses Q2 EPS by 3c
August 6, 2026 5:03 PM - StreetInsider
Form 10-Q Vaxart, Inc. For: Jun 30
August 6, 2026 4:33 PM - SEC Filing
Form 8-K Vaxart, Inc. For: Aug 06
August 6, 2026 4:24 PM - SEC Filing
Vaxart Provides Business Update and Reports Second Quarter 2026 Financial Results
August 6, 2026 4:06 PM - Globe NewsWire
Vaxart to Host Stockholder Fireside Chat on August 7 at 4:30 p.m. ET
July 30, 2026 8:00 AM - Globe NewsWire
Form 8-K Vaxart, Inc. For: Jul 27
July 28, 2026 8:00 AM - SEC Filing
Vaxart to Participate in BTIG Biotechnology Conference 2026
July 21, 2026 8:00 AM - Globe NewsWire
Form 4 Vaxart, Inc. For: Jul 16 Filed by: Finney Kevin
July 20, 2026 4:04 PM - SEC Filing
Form 4 Vaxart, Inc. For: Jul 16 Filed by: BREITMEYER JAMES B
July 17, 2026 9:51 PM - SEC Filing
Form 4 Vaxart, Inc. For: Jul 16 Filed by: HERON ELAINE J
July 17, 2026 9:51 PM - SEC Filing
Form 4 Vaxart, Inc. For: Jul 16 Filed by: Watson W. Mark
July 17, 2026 9:50 PM - SEC Filing
Form 4 Vaxart, Inc. For: Jul 16 Filed by: Wheadon David E.
July 17, 2026 9:50 PM - SEC Filing
Form 8-K Vaxart, Inc. For: Jul 16
July 17, 2026 4:10 PM - SEC Filing
Vaxart Announces Results of Annual Meeting of Stockholders
July 17, 2026 4:05 PM - Globe NewsWire
Form 8-K Vaxart, Inc. For: Jul 06
July 7, 2026 8:01 AM - SEC Filing
Vaxart reports no serious adverse events in oral COVID vaccine trial
July 6, 2026 4:01 PM - StreetInsider
Vaxart Reports Topline 12-Month Safety Data From the 400-Participant Sentinel Safety Cohort of the Phase 2b Clinical Trial of Its Oral Pill COVID-19 Vaccine
July 6, 2026 4:01 PM - Globe NewsWire
Form DEFA14A Vaxart, Inc.
July 6, 2026 6:10 AM - SEC Filing
Form DEFA14A Vaxart, Inc.
July 2, 2026 5:15 PM - SEC Filing
Form DFAN14A Vaxart, Inc. Filed by: Houle Daniel P
July 2, 2026 9:51 AM - SEC Filing
Form 8-K Vaxart, Inc. For: Jul 01
July 2, 2026 6:20 AM - SEC Filing
Form DEFA14A Vaxart, Inc.
July 1, 2026 4:08 PM - SEC Filing
Vaxart resolves proxy contest with stockholder cooperation deal
July 1, 2026 4:00 PM - StreetInsider
Vaxart Enters Cooperation Agreement with Stockholder Group and Announces Board and Corporate Governance Enhancements
July 1, 2026 4:00 PM - Globe NewsWire
Form DEFA14A Vaxart, Inc.
June 26, 2026 5:30 PM - SEC Filing
Form DEFA14A Vaxart, Inc.
June 26, 2026 5:24 PM - SEC Filing
Form 8-K Vaxart, Inc. For: Jun 22
June 26, 2026 4:08 PM - SEC Filing
Form DEFA14A Vaxart, Inc.
June 26, 2026 9:01 AM - SEC Filing
Form DEFA14A Vaxart, Inc.
June 26, 2026 8:55 AM - SEC Filing
Vaxart urges shareholder vote ahead of July proxy contest
June 26, 2026 8:01 AM - StreetInsider
Vaxart Publishes Presentation Urging Shareholders to Vote “FOR” ALL Six of the Company’s Highly Qualified Director Nominees on the WHITE Proxy Card TODAY
June 26, 2026 8:00 AM - Globe NewsWire
Vaxart gets $29M BARDA funding to advance COVID pill vaccine data
June 25, 2026 8:03 AM - StreetInsider
Vaxart Announces Update to BARDA Funding Award to Reflect Current Scope of COVID-19 Oral Pill Vaccine Trial
June 25, 2026 8:00 AM - Globe NewsWire
Form DFAN14A Vaxart, Inc. Filed by: Houle Daniel P
June 22, 2026 5:27 PM - SEC Filing
Form DEFA14A Vaxart, Inc.
June 16, 2026 5:23 PM - SEC Filing
Form DEFA14A Vaxart, Inc.
June 16, 2026 8:22 AM - SEC Filing
Vaxart’s Two Newest Independent Directors James Breitmeyer, M.D., Ph.D., and Kevin Finney Send Letter to Shareholders Ahead of 2026 Annual Meeting
June 16, 2026 8:00 AM - Globe NewsWire
Vaxart to Showcase Oral Vaccine Platform and Strategic Vision at BIO 2026 and Taiwan Biotech Forum
June 15, 2026 8:00 AM - Globe NewsWire
Form DFAN14A Vaxart, Inc. Filed by: Houle Daniel P
June 9, 2026 4:24 PM - SEC Filing
Vaxart to Participate in BTIG Infectious Disease Day 2026
June 9, 2026 8:00 AM - Globe NewsWire
Form DEFA14A Vaxart, Inc.
June 8, 2026 5:19 PM - SEC Filing
Form DFAN14A Vaxart, Inc. Filed by: Houle Daniel P
June 8, 2026 4:47 PM - SEC Filing
Form DEFA14A Vaxart, Inc.
June 8, 2026 8:14 AM - SEC Filing
Vaxart Urges Shareholders to Vote “FOR” ALL Six of the Company’s Highly Qualified Director Nominees on the WHITE Proxy Card TODAY
June 8, 2026 8:00 AM - Globe NewsWire
Full Article List
